INCREASED EXPRESSION OF B7-1 COSTIMULATORY MOLECULE ON CEREBROSPINAL-FLUID CELLS OF PATIENTS WITH MULTIPLE-SCLEROSIS AND INFECTIOUS CENTRAL-NERVOUS-SYSTEM DISEASE
A. Svenningsson et al., INCREASED EXPRESSION OF B7-1 COSTIMULATORY MOLECULE ON CEREBROSPINAL-FLUID CELLS OF PATIENTS WITH MULTIPLE-SCLEROSIS AND INFECTIOUS CENTRAL-NERVOUS-SYSTEM DISEASE, Journal of neuroimmunology, 75(1-2), 1997, pp. 59-68
The expression of the costimulatory molecule B7-1 (BB-1; CD80) and its
ligand CD28 was investigated on peripheral blood (PB) and cerebrospin
al fluid (CSF) T and B lymphocytes and monocytes in 11 patients with r
elapsing-remitting multiple sclerosis (MS), 21 age-matched healthy con
trols and 10 patients with central nervous system (CNS) infectious dis
ease (CID). Three channel flow cytometry was used with a novel gating
technique in order to unambiguously identify the low numbers of B lymp
hocytes present in normal CSF. There was a significantly higher fracti
on of B7-1(+) B lymphocytes in the CSF of patients with MS (72%) and C
ID (69%) when compared with healthy individuals (53%; p < 0.0001 and p
< 0.002, respectively). Furthermore, two patients with a clinical pic
ture of encephalitis showed a profoundly increased B7-1 expression on
CSF monocytes. Comparison of absolute numbers of B7-1(+) B lymphocytes
/mL CSF between MS patients and healthy controls revealed a highly inc
reased frequency of these cells among MS patients (235 cells/mL in MS
patients versus 3.9 cells/mL in controls; p < 0.0001) with no overlap
between the groups, which was otherwise seen for all other analyzed ce
ll populations. We therefore hypothesize that activated B lymphocytes
expressing high levels of B7-1 may be of pathogenetic importance in th
e development and maintenance of the MS disease.